Weekly Roundup -
April 29, 2026
Smart. Strategic. Essential.
Unmatched Healthcare Insights from ºìÁì½í¹Ï±¨,
Leavitt Partners & Wakely.
Featured:
ºìÁì½í¹Ï±¨â€™s Experts Support States in Rural Health Initiatives
READ SPOTLIGHTFrom Crisis to Coordinated Care: Six Behavioral Health Priorities for Hospitals and Health Systems
READ SPOTLIGHTTrending: In Focus
Early Signals from a Pivotal ACA Enrollment Year
On April 15,Ìý2026,ÌýWakely ConsultingÌýGroup, an ºìÁì½í¹Ï±¨Ìýcompany,ÌýpublishedÌý“,†the firstÌýcomprehensive nationwide look atÌý2026 enrollment trends in theÌýAffordable Care Act (ACA)Ìýmarket.ÌýWhileÌýthe Centers for Medicare & Medicaid Services (CMS)Ìýhas released 2026 planÌýselectionÌý,Ìýthe Wakely reportÌýaddressesÌýwhoÌýretainedÌýcoverageÌýand who did not, what we stillÌýdon’tÌýknow, and what we should be watching for throughout the rest of the 2026 plan year.Ìý
This article highlights key findingsÌýinÌýthe report, related state-level data,ÌýimpactsÌýand takeaways, and actions states and otherÌýinterest-holdersÌýshould consider as they look to mitigate further coverage losses andÌýaddress market stabilityÌýinÌýplan year 2027 and beyond.Ìý
Key FindingsÌýfrom theÌýACA Marketplace Early Enrollment TrendsÌýReportÌý
TheÌý report is based on analysis of data from the Wakely National Risk Adjustment Reporting (WNRAR) project, which includes summary data from participating ACA-compliant individual market plans.ÌýWNRAR includes data from overÌý75 issuersÌýrepresentingÌýnearly 80 percentÌýofÌýenrollmentÌýthe individual market.ÌýKey national findingsÌýinÌýthe report include:Ìý
- Only 86% of enrollees paid their January 2026 premium.Ìý
- State variation is significant, ranging from as low as 63% paid in January to as high as 99%.Ìý
- The overallÌýaverageÌýenrollment decrease is estimatedÌýto be betweenÌý17% andÌý26% lower than 2025,Ìýwith morbidity projected to worsenÌýbyÌý2.9–6.5%.Ìý
The report highlightsÌýshiftsÌýin planÌýchoiceÌýactivityÌýdriven by affordability pressures,Ìýwhich resulted inÌýconsiderable migration away from richer benefit plans to plans with lower premiums and higher out-of-pocket maximums. Examples include:Ìý
- Silver plan enrollment fellÌýapproximatelyÌý17% from 2025.Ìý
- Bronze enrollment increased by more than 10%.Ìý
- More thanÌý13% ofÌý2025ÌýGold plan enrolleesÌýselected a lowerÌýpriced,ÌýBronzeÌýtier planÌýin 2026.Ìý
The report alsoÌýdemonstratedÌýthe importance and value of outreach, operational excellence, andÌýstate-level affordabilityÌýmitigation strategies. Examples include:Ìý
- Enrollment decreases are lower inÌýstates withÌýstate-based marketplacesÌý(SBMs)Ìýand expected to stay lower than Healthcare.gov states, largelyÌýbecause ofÌýproactive outreach and marketing initiatives,Ìýlower net premium increases,Ìýand stateÌýaffordabilityÌýprograms.Ìý
- States with premium alignment and silver-loading as a policy lever for improving gold plan affordability are seeing results. Gold plan enrollment increased by 10 percentage points in states where gold plans cost less than silver plans, whereas gold enrollment did not materially change in states where silver plans cost less. For states, this provides a lever to assist consumers seeking to shift into plans with lower cost-sharing without increasing premiums.
State-ReportedÌýEarly Enrollment ResultsÌý
Many states warned of coverage losses as a result of changing federal policies and the expiration of enhanced premium tax credits (ePTCs). State-specific reporting for 2026 validates the findings in the Wakely report. The recently released state-level data from SBMs affirms that the drop-off in enrollment through cancellations and dis-enrollments is significant. It also illustrates that state efforts to mitigate and address affordability gaps have worked to some extent but have not been enough on their own to head off coverage losses in 2026. Examples are as follows:Ìý
- InÌýGeorgia—theÌýonly SBM without Medicaid expansion—enrollmentÌýÌý27% from an estimatedÌý1.3Ìýmillion inÌýAprilÌý2025 to approximatelyÌý950,000ÌýinÌýApril 2026.Ìý
- InÌýNewÌýJersey—aÌýstateÌýwith state-funded premium subsidies,Ìýa reinsurance program, and a mandateÌýthatÌýresidents have healthÌýinsurance—enrollment hasÌýÌýby more than 11%ÌýsinceÌýApril 2025.Ìý
- InÌýCalifornia—another state with premium subsidies,ÌýfacilitatedÌýenrollment,Ìýand an individual mandate—effectuatedÌýenrollmentÌýÌýby 7%Ìýfrom February 2025 to February 2026.Ìý
- Overall, SBMs areÌýÌýthat coverage dropsÌýwereÌý24% higher from January to March 2026 thanÌýduringÌýthe same period in 2025 and thatÌýthe rate of plan shifting from Silver to BronzeÌýincreasedÌýsignificantly,ÌýquadruplingÌýin six states.Ìý
Downstream Impact onÌýHealthcare AccessÌýand Uncompensated CareÌý
While not yet apparent in the early enrollment data, the downstream impact of 1) coverage losses, 2) increased enrollment in plans with higher cost-sharing, and 3) a worsening risk pool on the health of consumers, as well as the healthcare system, will be significant. Consumers may decide to postpone or forgo necessary care, which could lead to avoidable and more costly healthcare conditions. Increases in the number of people who uninsured and underinsured will have a direct and negative economic impact on provider finances, which are already strained, and uncompensated care and demands on patient assistance programs will increase accordingly.Ìý
Looking AheadÌý
The individual market will continue to evolve and change in the coming years as a result of future regulatory and operational changes. A shortened Open Enrollment Period, increased Medicaid redetermination requirements, and new pre-enrollment verification requirements are notable initiatives that are expected to roll out in the coming years.
Healthcare organizations and government agencies should consider the effect of these changes, including further coverage losses and instability in the individual market driven by the administrative complexity of these changes.
In addition,Ìýthere areÌýpotential federalÌýchanges such as expanded availability of catastrophic plans, the introduction of non-network plans, andÌýadditionalÌýeligibility changes,ÌýwhichÌýcould put further strainÌýon ´¡°ä´¡Ìý²Ñ²¹°ù°ì±ð³Ù±è±ô²¹³¦±ð operations and the individualÌýmarket.
Getting ahead of these changes will be critical to mitigating coverage losses and ensuring the long-term stability and viability of the individual market. In a federal policy environment that has largely deferred acting on ACA affordability, we expect policymakers, issuers, and other interest-holders to increasingly look to governors and state legislatures for decisive action. State subsidy and reinsurance programs are established affordability mechanisms that canÌýprovide consumers with affordability reliefÌýquickly, assuming state funding is available.
These investments can pay off for consumers from an economic perspective as well. For every additional dollar spent on state subsidies or reinsurance to maintain or increase coverage, states can expect to see reductions in uncompensated care, less reliance on patient assistance programs, and decreases in the number of consumers who forgo or delay care. In addition, investments in enrollment operations and assistance, outreach, and education will be critical to ensuring consumers are aware of the changes ahead and the actions they need to take to access and stay covered.
Connect with UsÌý
ºìÁì½í¹Ï±¨, Inc. (ºìÁì½í¹Ï±¨),Ìýand WakelyÌýcolleaguesÌýare closely tracking federal policy activity and state actions to address these challenges. Our experts support states,Ìýissuers, consumer groups, and other interest-holders to achieve success in the operation of and participation in the marketplaces. Our team has broad historical knowledge of the challenges and opportunities in this market and can support every step of the planning and execution processes toÌýimprove affordability and stabilityÌýasÌýitÌýevolvesÌýin the coming months and years.Ìý
ContactÌýLina Rashid,ÌýZach Sherman, orÌýÌýwith questions about the report andÌýto discuss opportunities to address the trends and forthcoming changes in the market.Ìý
To read more about theÌýchanges ahead, see the following reports:Ìý
Outlook 2026: A Conversation on Medicare Draft Payment Rules
AsÌýthe Centers for Medicare & Medicaid Services (CMS)Ìýadvances throughÌýthe 2027 Medicare payment rule cycle, stakeholders across Medicare Advantage (MA) and the provider community are assessing how proposed changesÌýcouldÌýaffect payment,Ìýutilization, and longer-term revenue.ÌýTo better understand what to watch as draft rules move toward finalization,ÌýJen Colamonico, Vice President, Strategy and Communications at ºìÁì½í¹Ï±¨ (ºìÁì½í¹Ï±¨), caught up withÌý,ÌýSeniorÌýConsulting Actuary with Wakley, an ºìÁì½í¹Ï±¨ Company. Of particular interest was CMS’sÌýdecision toÌýeliminateÌýthe Inpatient Only List (IPO) over a three- yearÌýperiod.Ìý
Q: As CMS begins releasing draft payment rules for 2027, what stands out most to you from aÌýbudgetaryÌýperspective?
Rachel: Timing and uncertainty really stand out. These policies don’t operate in isolation. Changes to Medicare fee-for-service (FFS) payment ultimately affect Medicare Advantage benchmarks, provider contracting, and long-term revenue expectations. Because bids, budgets, and contracts are set before rules are finalized, modeling different scenarios becomes essential.Ìý
Q:ÌýOne issue that has garnered significant interest is CMS’sÌýdecision to phase outÌýMedicare’s Inpatient Only (IPO)Ìýpolicy,Ìýwhich is aÌýlist of procedures and services that must be provided on an inpatient basis.ÌýInÌý2026, CMS eliminatedÌýnearly 300 services,Ìýmostly musculoskeletal services,Ìýfrom the IPO list.ÌýHow are Medicare Advantage plans thinking about theÌýInpatientÌýOnly list specifically?Ìý
Rachel:ÌýHistorically, many MA plans have followed theÌýIPOÌýpolicyÌýeven though theyÌýweren’tÌýrequired toÌýdo so, largely because it simplified operations and aligned with Medicare fee-for-service payment systems. Plans do have flexibility in how they contract with providers, and we see a wide range of approaches in the market. Some contracts closely mirrorÌýFFS, while others incorporate more customized arrangements or risk sharing. Because of that, the direct impact of IPO changes will vary significantly across plans and provider relationships.Ìý
Q: Where do you see the biggest potential impact for Medicare Advantage?
Rachel:ÌýI think the bigger impact may be indirect rather than tied to individual contract changes. Medicare Advantage benchmarks are driven by underlying fee-for-service spending trends. If CMSÌýanticipatesÌýlower overall inpatient spending as procedures move to outpatient or ambulatory surgical center settings, that expectation could show up in benchmark growth rates. Even relativelyÌýsmall changesÌýinÌýbenchmark growth can affect plan revenue, rebates, and benefit flexibility.Ìý
Q: Are you already seeing signs of that in the data?
Rachel:ÌýWe do see lower inpatient trends reflected in the 2027 and 2028 US per capita cost projections.ÌýIt’sÌýstill unclearÌýwhat’sÌýdriving those trends—whether its assumptions related toÌýthe IPOÌýlistÌýremoval or other factors.ÌýWe’veÌýasked CMS for more clarity. From an actuarial standpoint, understandingÌýwhat’sÌýbaked into those projections is critical, because so many MA financial decisions flow from them.Ìý
Q: How does this uncertainty affect provider planning,Ìýespecially forÌýhospitals?
Rachel:ÌýProviders are understandably concerned about potential revenue shifts if cases move out of the inpatient setting. But in Medicare Advantage, the picture is more nuanced than in fee-for-service. Many MA arrangements include risk sharing, medical loss ratio targets, and quality incentive payments. If overall costs decline, providers mayÌýshare inÌýsavings through those mechanisms. So,Ìýwhile there may be pressure on inpatient revenue,Ìýit’sÌýnot necessarily a oneÌýdirectional loss.Ìý
Q: Does that mean the overall impact may be less dramatic than it appears?
Rachel: Potentially, yes—especially for organizations already participating in value-based arrangements. A reduction in unit costs doesn’t automatically mean a reduction in total provider revenue in MA.ÌýThe redistribution of dollars through shared savings and quality bonuses can offset some of that pressure. That’s why understanding contract structure is just as important as understanding the policy itself.Ìý
Q: What about quality and patient safety as procedures move to lowerÌýcost settings?
Rachel: Quality is always central in Medicare Advantage, and plans are already managing a lot of complexity related to Star ratings and quality measurement. We haven’t yet seen specific quality safeguards tied to the IPO list changes, but I would expect more discussion in the forthcoming proposed rules.ÌýFrom the MA side, contracting remains a key lever. Plans still have flexibility to ensure procedures are performed in appropriate settings and to align incentives with quality outcomes.Ìý
Q:ÌýWhat stepsÌýdoÌýyou recommend toÌýstakeholdersÌýtoÌýprepare for the final rule and for 2027?
Rachel:ÌýModeling helps organizations understand the range ofÌýpossible outcomesÌýrather than betting on a single assumption.ÌýWe’reÌýlooking at differentÌýutilizationÌýscenarios, siteÌýofÌýcare shifts, and benchmark growth trajectories. For providers, modeling can inform contract negotiations and capital planning. For plans, it helps assess revenue risk and benefit design flexibility. ItÌýdoesn’tÌýeliminateÌýuncertainty, but it helps organizations make informed decisions.Ìý
Q: If you could change one thing about how these policies are rolled out, what would it be?
Rachel:ÌýTransparency. The more clarity CMS can provide around cost projections and assumptions—especially those affecting benchmarks—the better positioned actuaries, plans, and providers will be to respond. So much of Medicare Advantage pricing relies on understanding how fee-for-service is expected to evolve. Greater transparency helps everyone plan more responsibly.Ìý
ºìÁì½í¹Ï±¨â€™s Medicare Practice Group Can HelpÌý
As CMS moves closer toÌýfinalizingÌýthe 2027 payment rules, actuarial modelingÌýwill continue to beÌýan importantÌýtoolÌýfor translating policy direction into financial strategy. For MA plans and providers alike, early analysis and scenario planning can help mitigate riskÌýandÌýidentifyÌýopportunityÌýas Medicare’s payment landscape continues toÌýevolve.Ìý
ForÌýadditionalÌýinsights, listen to Rachel StewartÌýand Zach GaumerÌýonÌýºìÁì½í¹Ï±¨â€™s Vital ViewpointsÌýpodcast.ÌýLearn more aboutÌýourÌýMedicare services and solutions.Ìý
Federal Policy News
Fueled By Weekly Health Intelligence
CMS Introduces RAPID Model to Streamline Breakthrough Device Coverage
On April 23,Ìýthe Centers for Medicare & Medicaid Services (CMS)ÌýandÌýthe U.S. Food and Drug Administration (FDA)ÌýÌýa new Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, which is intended toÌýexpediteÌýMedicare coverage of certain Class II and III Breakthrough Devices.ÌýToÌýexpediteÌýcoverage, CMS willÌýparticipateÌýin engagements between FDA and eligible device manufacturers during FDA’s premarket review process.ÌýEligible devices will be those subject to an Investigational Device Exemption (IDE) study involving Medicare beneficiaries thatÌýstudiesÌýclinical health outcomes agreed upon by FDA and CMS.ÌýIn a call withÌýpress, Administration officialsÌýÌýthat about 40 devices would currently be eligible for the RAPID pathway, and anÌýadditionalÌý20 devices could potentially qualify.ÌýIf an eligible device receivesÌýFDAÌýmarket authorization, CMS will issue a proposed National Coverage Determination (NCD) on the same day. The proposed NCD will then be subject to a 30-day,Ìýstatutorily-requiredÌýpublic comment period, such that CMS expects the process could enable “predictable Medicare national coverage and payment as soon as two months after market authorization.â€Ìý
CMSÌýplans toÌýpost a proposed procedural notice in the Federal Register, which will outline the RAPID coverage pathway in more detail. There will be a 60-day public comment period on the procedural notice, and then CMS will issue a final notice that includes the effective date of the new coverage pathway.ÌýÌý
Expediting Medicare coverage of breakthrough devices has been an issue for many years, as the first Trump AdministrationÌýfinalizedÌýthe Medicare Coverage of Innovative Technology (MCIT) rule, which created a pathway for breakthrough devices to receive automatic Medicare coverage in a transitional period while awaiting the determination for permanent coverage. The Biden Administration repealed the MCIT rule and created the narrowerÌýsubregulatoryÌýTransitional Coverage for Emerging Technologies (TCET) pathway in 2024. The RAPID press release noted that CMS will pause the TCET to new candidates.Ìý
 Medicare coverage for breakthrough devices has also been the subject of bipartisan legislation, including theÌý, which passed the House Ways & Means Committee in 2024 and 2025. The bill would require Medicare to automatically cover certain medical devices for a four-year period following approval from FDA. The Congressional Budget Office (CBO) estimatedÌýtheÌýÌýwould increase net Medicare spending by about $994 million over ten years.Ìý
FDA Advances Psychedelic Drug Development for Serious Mental Illness
On April 24, FDA announced several actions to advance the development of psychedelic medications to treat serious mental illness (SMI). FDAÌýannounced that it is issuing national priority vouchers to three companies studying:Ìý
- Psilocybin for treatment-resistant depression;Ìý
- Psilocybin for major depressive disorder; andÌý
- Methylone for post-traumatic stress disorder (PTSD).Ìý
Additionally, FDA approved a Phase I clinical study of noribogaine hydrochloride, a “psychoactive indole alkaloid derived from the African TabernantheÌýiboga shrub,†for the potential treatment of alcohol use disorder. FDA also announced that it will be imminently issuing final guidance onÌýdevelopmentÌýof products and clinical trials to evaluate serotonin-2A agonists.Ìý
The FDA announcements follow anÌý (EO) directing the agency to issue priority review vouchers for psychedelic drugs that have received breakthrough therapy designations for treatment of SMI and to increase access to clinical trials and investigational drugs. The EO also directed the Advanced Research Projects Agency for Health (ARPA-H) to provide funding for psychedelics research, which the agency Ìýon April 21.Ìý
AHRQ Seeks Nominations for U.S. Preventive Services Task Force
On April 23, AHRQÌýÌýa notice in the Federal Register seeking nominations for new members of the U.S. Preventive Services Task Force (USPSTF). The USPSTF is a Federal Advisory Committee that makes recommendations on clinical preventive services, which thenÌýimpactsÌýinsurance coverage. In the notice, AHRQ “encourages nominations of physician specialists in anesthesiology/pain management, cardiology, endocrinology, family medicine, gastroenterology, hematology/oncology, internal medicine, obstetrics and gynecology, pediatrics, preventive medicine, radiology, and experts in health economics.†The nomination deadline for the USPSTF is May 23, 2026, with appointments beginning in June 2026.Ìý
New National Strategy Aims to Strengthen Home Visiting Workforce
On April 21, 2026, The Health Resources and Services Administration (HRSA) released theÌý, outlining a framework for strengthening and expanding the workforce that supports evidence-based maternal and child health programs. The strategy is closely tied to HRSA’s Maternal, Infant, and Early Childhood Home Visiting () program, which delivered more than one million home visits to over 150,000 parents and children in FY2025. The strategy is composed of three pillars—creating career pathways, strengthening the workforce, and supporting workforce well-being—that seek to address long-standing sector challenges. Emphasis on compensation, supervision and leadership development, data-informed workforce planning, and reduced administrative burden signals a shift toward professionalization and focus on retention in the home visiting field. The strategy underscores HRSA’s broader move toward sustainability and systems-building, reinforcing home visiting as a durable investment where long-term impact depends on a stable, skilled, and supported workforce.Ìý
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
Alabama Releases MMIS RFP
The Alabama Medicaid Agency  on April 22, 2026, a request for proposals (RFP) seeking qualified vendors to take over the Alabama Medicaid Management Information System (AMMIS). The state is seeking a contractor that will modernize MMIS, implement enhancements, andÌýmaintainÌýand operate the resulting Claims Processing and Management Services system. The selected contractor will work in three phases: takeover, maintenance and operations, and enhancement. The contract, which is expected to begin July 1, 2027, will run forÌýan initialÌýfour-year contract term, if approved by the Alabama Legislature’s Contract Review Committee, with two optional two-year extensions. If the committee does not approve an initial four-year contract, the contract willÌýrun forÌýan initial two years with three optional two-year extensions. Proposals are due on September 22, 2026, and the state intends to award the contract by July 1, 2027. GainwellÌýoperatesÌýAlabama’s current MMIS system.Ìý
Arizona, Illinois Seek Vendors to Provide Medicaid Work Requirement Outreach Assistance for Upcoming Federal Changes
The Arizona Health Care Cost Containment System  on April 24, 2026, a task order for statewide communications and engagement support related to H.R. 1 community engagement/work requirements, six-month renewals, and member address updates. The selected contractor will support stakeholder input, message development, public-facing communications, provider and partner toolkits, creative assets, web and social media content, campaign implementation, and performance monitoring. Responses are due May 28, 2026, and public-facing communications are expected to begin no later than September 1, 2026, subject to federal approval.Ìý
The Illinois Department of Healthcare and Family Services  on April 16, 2026, an Invitation for Bid (IFB) seeking a vendor to lead full-service communications, advertising, media planning, and media buying for outreach to help Medicaid customers understand potential eligibility impacts and required actions outlined in the federal 2025 budget reconciliation act (P.L 119-21, OBBBA). Bids are due by May 14. The resulting contract will begin upon final execution andÌýrun forÌýan initialÌýterm of up to five years, and the total term cannot exceed 10 years.Ìý
Florida to Implement New Children’s Medical Services Contract October 1
The Florida Agency for Health Care Administration (AHCA)  on April 28, 2026, that it will be transitioning the Children’s Medical Services (CMS) Plan from the current Centene/Sunshine State Health Plan to Molina Healthcare of Florida on October 1, 2026. Molina was awarded the contract in November 2025. There will be a continuity of care period through May 31, 2027.Ìý
Michigan Releases Draft 2027–2029 State Plan on Aging
The Michigan Department of Health and Human Services  on April 23, 2026, that it is accepting public comments on its draft 2027–2029 State Plan on Aging, a multiyear roadmap for how the state will support older adults, family caregivers, and aging services providers. Developed by the department’s Bureau of Aging, Community Living, and Supports, the plan was shaped by a statewide needs assessment, surveys, interviews, and community conversations with older adults, caregivers, and partner organizations. It outlines four main priorities: improving access to services, strengthening coordination across state agencies and local partners, making it easier for people to find available resources, and using language that better reflects the value of aging and caregiving. Public comments are due by May 21.Ìý
Texas to Release Medicaid, CHIP Dental Services RFP Q1 SFY27
The Texas Health and Human Services Commission  on April 17, 2026, plans to release a Request for Proposals (RFP) for Medicaid and Children’s Health Insurance Program dental services in Q1 of state fiscal year 2027, which begins September 1, 2026. The procurement covers statewide managed care dental services for children, with contractors responsible for providing preventive and primary dental care and building provider networks that include general dentists, pediatric dentists, and specialists. The current incumbents areÌýDentaQuest, MCNA, and UnitedHealthcare.Ìý
Private Market News
Fueled By
Stakeholders Weigh in on Labor Department’s Pending PBM Transparency Rule
A broad coalition of employers, lawmakers, and healthcare groups is urging the U.S. Department of Labor toÌýfinalizeÌýa rule requiring toÌýdiscloseÌýdetailed pricing and compensation data, arguing it would improve transparency and lower drug costs. PBMs oppose the rule, calling it government overreach and warning it could harm competition and duplicate existing regulations. The proposal reflects growing pressure to regulate PBMs, though debate continues over how extensive the transparency requirements should be.Ìý
Our Insights
Fueled By Experts Across Our ºìÁì½í¹Ï±¨ Companies
ºìÁì½í¹Ï±¨
Saving Lives with Compassion: Overdose Response Training with RiVive®
ThisÌýwebinarÌýwill present findings from the 2025ÌýRiVive Community Engagement Report and best practices in Compassionate Overdose Responseâ„¢, with a focus on the community use of RiViveÌýnaloxone nasal spray 3 mg. A panel of expert speakers will present their protocols for effective overdose intervention, guidance on the training of others, and strategies for integrating trauma-informed approaches into post-overdose care. Designed for program teams, medical professionals, and harm reduction leaders, anyone who attends will leave with research and experience-backed methods for improving outcomes in opioid overdose emergencies. A recording of thisÌýwebinarÌýwill be available after this session, with a link to the 2025 report.Ìý
Webinar Replay: Achieving Success with New Technology Add-on Payment (NTAP): What Life Sciences Companies Need to Know
OnÌýApril 22, ºìÁì½í¹Ï±¨ consultants hostedÌýa webinarÌýforÌýlife sciences companiesÌýseekingÌýto navigate the New Technology Add-on Payment (NTAP) program.ÌýTheÌýreplayÌýis now available and can be viewed to supportÌýdrug, device, and diagnostic manufacturers with a clear understanding of eligibility requirements, the application process, and how to strategically position products for approval. Experts also broke down CMS evaluation criteria and highlighted key updates shaping the NTAP program in 2026 and 2027.
2026 Michigan State of Reform Health Policy Conference | May 5, 2026
The 2026 Michigan State of Reform Health Policy Conference will be taking place in-person on May 5th,Ìý2026Ìýat the Kellogg Hotel and Conference Center!ÌýManaging constant change in healthcare takes more thanÌýjust hardÌýwork. It takes a solid understanding of the legislative process and knowledge aboutÌýintricaciesÌýof the healthcare system.ÌýThat’sÌýwhereÌýStateÌýof Reform comes in.
2026 Maryland State of Reform Health Policy Conference | May 21, 2026
The 2026 Maryland State of Reform Health Policy Conference will be taking place in-person on May 21st, 2026 at the Baltimore Marriott Waterfront! Managing constant change in healthcare takes more than just hard work. It takes a solid understanding of the legislative process and knowledge about intricacies of the healthcare system. That’s where State of Reform comes in.
Wakely
2026 ACA Open Enrollment – What Happened?
On April 15, 2026, Wakely Consulting Group, a ºìÁì½í¹Ï±¨, Inc. Company, released a paper titled,Ìý.ÌýIn the next paper in our series,Ìýwe estimate a material reduction in individual ACA enrollment for 2026, ranging on average from 17% to 26% in total. We estimate that morbidity could be, on average, between 2.9% and 6.5% worse as a result. This analysis was based on a unique data collection from the Wakely National Risk Adjustment Reporting (WNRAR) project. This paperÌýcontainsÌýinsights not provided by publicly available data releasesÌýandÌýsummarizes key insights based on an evaluation of theÌýdata from the March 2026ÌýCenters for Medicaid & MedicareÌýServices’Ìý(CMS) Open Enrollment (OE) Report.ÌýÌý
When Stars Realign: Understanding CMS’s 2027 Final Rule
This white paper provides an overview and impact analysis of the Star Rating changesÌýfinalizedÌýin the 2027 Medicare Advantage and Part D Final Rule issued by CMS. This version of the paper updatesÌýÌýon the proposed rule.ÌýÌýFindings include:Ìý
- Key components of the upcoming Star Rating changesÌý
- Analysis of impacts across major parent organizations and the market as a wholeÌý
- Brief discussion of the future of Star Ratings and how plans can prepare for upcoming changesÌý
ºìÁì½í¹Ï±¨ Spotlight
Connected Crisis Care: Generating Collaborative Solutions for 988 and Beyond
Read MoreRFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: February 2026 - DELAYED | State/Program: Illinois | Event: Awards | Beneficiaries: 2,400,000 |
| Date: May 1, 2026 | State/Program: Nevada Children's Specialty | Event: Proposals Due | Beneficiaries: NA |
| Date: May 12, 2026 | State/Program: Nevada CO D-SNP | Event: Awards | Beneficiaries: 88,000 |
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: Summer 2026 | State/Program: Illinois Foster Care | Event: RFP Release | Beneficiaries: 33,000 |
| Date: July 1, 2026 | State/Program: Hawaii Community Care Services | Event: Implementation | Beneficiaries: 5,500 |
| Date: July 28, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: August 2026 | State/Program: Indiana | Event: RFP Release | Beneficiaries: 1,400,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada CO D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2027 | State/Program: Illinois Tailored Care Management Program | Event: Implementation | Beneficiaries: 22,400 |
| Date: July 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |
| Date: 2029 | State/Program: California | Event: RFP Release | Beneficiaries: NA |